KoreSummit Helps Companies and Entrepreneurs in the Health Industry Raise Capital Compliantly

2022年06月08日21:00

Medtech, Biotech, and Pharma industries will gather for the Medtech A+ Team - how to do a successful RegA+ for a Medtech company in a different format, with quicker panels and more information

Featured Image for KoreConX

Featured Image for KoreConX
Featured Image for KoreConX
Featured Image for KoreConX

NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- The health industry has important challenges to overcome regarding research, technology, and financing. KoreConX and KorePartners have put together the KoreSummit Medtech A+ Team, which aims at helping companies raise capital compliantly using Regulation A (RegA+). The online event takes place on June 23, at 1 p.m. (EDT).

The first panel will bring together Oscar A Jofre, KoreConX's CEO and co-founder; Stephen Brock, CEO at Medical Funding Professionals; and Scott Pantel, co-founder and CEO of Life Science Intelligence, to show how to start this journey.

With panels programmed for no longer than 45 minutes, speakers will explore topics with real-life experience. Other topics encompass the Form 1A (Legals, Accounting, Broker-Dealer, Escrow), the go-live preparation (Investor Acquisition, Broker-Dealer, Issuance Technology, SEC-Transfer Agent), potential investors engagement and secondary marketing trading ATS.

"The JOBS Act has been reshaping the private capital market, so we thought about this KoreSummit as a journey: from the beginning, with the Form 1A, the legal aspect, the preparation, how to engage people, sell the story rather than sell the stock. It is a great opportunity to be closer to KorePartners and the best way to strengthen the Medtech ecosystem," says Oscar A Jofre.

Innovation has been part of this business since the beginning of Medicine studies, which makes Scott Pantel an enthusiast of RegA+. Pantel thinks of it as a way to make things happen, while providing the population with greater life quality, as he already stated in KoreConX's blog: "In the many years I've been working with Medtech innovators, I can't count the number of great products I've seen that never make it to market for lack of access to capital." As innovative as the Medtech business, Manny Villafaña, Ph.D.Sc., founder and CEO of Medical 21, sums it up: "Regulation A+ is the 21st Century way to raise capital." Not to mention the impact of the RegA+ bill on capital formation and job creation.

The full schedule and sign-up form can be accessed directly at the site event.

About KoreConX

Founded in 2016, KoreConX is the first secure, All-In-One platform that manages private companies' capital market activity and stakeholder communications. With an innovative approach and to ensure compliance with securities regulations and corporate law, KoreConX offers a single environment to connect companies to the capital markets and now secondary markets. Additionally, investors, broker-dealers, law firms, accountants and investor acquisition firms, all leverage our eco-system solution. For investor relations and fundraising, the platform enables private companies to share and manage corporate records and investments: it assists with portfolio management, capitalization table and shareholder management, virtual minute book, security registration, transfer agent services, and virtual deal rooms for raising capital.

###

Media Contacts:

KoreConX

Rafael Gonçalves

rafael@koreconx.com

Related Images

Image 1

This content was issued through the press release distribution service at Newswire.com.

Attachment

關注我們Facebook專頁
    相關新聞
      更多瀏覽